Classification and treatment of endometrial cancer

What is endometrial cancer?

1. Endometrial cancer is a malignant tumor originating from the endometrium. According to whether it is responsive to estrogen, it can be divided into estrogen-dependent and non-estrogen-dependent types. The non-estrogen-dependent type has a poor prognosis. In terms of pathological classification, the vast majority are endometrioid carcinomas, which are histologically classified as grade 3. The higher the grade, the worse the prognosis. Abnormal vaginal bleeding is a common symptom. Diagnostic curettage and hysteroscopic biopsy are commonly used diagnostic methods. The diagnosis is based on histopathological examination.

2. Patients with early-stage endometrial cancer choose surgical treatment and undergo staging surgery for endometrial cancer. After surgery, the corresponding adjuvant treatment is selected based on the presence or absence of high-risk factors that affect prognosis. Advanced patients are treated with a variety of comprehensive treatments such as surgery, radiation, and drugs. Patients with fertility requirements can also choose to retain their fertility if they meet the conditions. For example, high-dose progestin therapy, clinical use of oral medroxyprogesterone, megestrol acetate, etc.

3. Endometrial cancer is a group of epithelial malignant tumors that occur in the endometrium, with adenocarcinoma originating from the endometrial glands being the most common. It is one of the three common malignant tumors of the reproductive tract. It accounts for about 7% of all malignant tumors in women and 20% to 30% of malignant tumors in the female reproductive tract. In recent years, the incidence rate has increased year by year and is on the rise worldwide. The average age of onset is 60 years old, and more than 75% of them occur in female patients over 50 years old.